CB2 Insights

CB2 Insights announces new ticker symbol on OTC markets

The cannabis data analytics company will continue trading on the OTCQB under the new symbol 'CBIIF'

doctor holding cannabis
CB2 Insights is a medical cannabis-focused data firm

CB2 Insights (CSE:CBII) (OTCMKTS:CBIIF) announced Friday that it has changed its OTCQB ticker symbol to “CBIIF.”

The cannabis data analytics company will continue to trade on the Canadian Securities Exchange under the symbol “CBII.”

READ: CB2 Insights strengthens board with new member and appoints chairman

Based in Toronto, CB2 Insights is a medical cannabis-focused data firm. The company is busy meeting what it says is significant demand by building a data asset covering the medical cannabis sector by providing predictive analytics tools, data-driven software and services. In addition, it operates 28 cannabis evaluation and education clinics in 12 US states.

CB2 Insights said in a statement Friday that no action is required by shareholders in connection with the ticker symbol change.

Shares of CB2 closed Thursday up 2% to C$0.26 on the Canadian Securities Exchange and were trading at US$0.20 on the OTCQB.  

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: CB2 Insights

Price: $0.14

Market: CSE
Market Cap: $11.03 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of CB2 Insights named herein, including the promotion by the Company of CB2 Insights in any Content on the Site, the Company receives from said...



Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

6 hours, 3 minutes ago

2 min read